Helsinn Therapeutics (u.s.), INC.
Doing business as Helsinn Therapeutics US INC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersIselin, NJ
US patents9
SAM.gov UEIH7RDUVXHP8L3
CAGE code7UCK3
Incorporated inDE
- global pharmaceutical
- commitment
- chronic diseases
- licensing
- technical organization
- initiatives
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
9 US patents granted 2010–2014, none of them in the five years to SEP 2025.
Pharmaceuticals 5Organic fine chemistry 4
- Enhanced migraine treatments based on ghrelin mimeticsUS 8,673,947 · granted MAR 18, 2014
- Enhanced migraine treatments based on ghrelin mimeticsUS 8,486,976 · granted JUL 16, 2013
- Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazideUS 8,466,173 · granted JUN 18, 2013
- Methods of treating emesis using growth hormone secretagoguesUS 8,394,833 · granted MAR 12, 2013
- Methods of treating emesis using growth hormone secretagoguesUS 8,288,427 · granted OCT 16, 2012
Newest 5 shown · Granted to Helsinn Therapeutics (U.S.), Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Helsinn Therapeutics (u.s.), INC. | Iselin | NJ | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


